Michel Dahan
Chief Operating Officer bei AKEBIA THERAPEUTICS, INC.
Vermögen: 1 Mio $ am 31.03.2024
Profil
Michel Dahan is currently the Director at Alkeus Pharmaceuticals, Inc. since 2023 and the Chief Operating Officer & Senior Vice President at Akebia Therapeutics, Inc. since 2013.
Previously, he worked as the Director-International Product at Ipsen, Inc. from 2003 to 2010 and as the VP-Commercial Development & Strategic Planning at Inspiration Biopharmaceuticals, Inc. from 2010 to 2013.
Mr. Dahan holds a graduate degree from Université Pierre et Marie Curie and an undergraduate degree from École des Hautes Études Commerciales de Paris.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 29.02.2024 | 706 932 ( 0,34% ) | 1 Mio $ | 31.03.2024 |
Aktive Positionen von Michel Dahan
| Unternehmen | Position | Beginn |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Chief Operating Officer | - |
Alkeus Pharmaceuticals, Inc.
 Alkeus Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Alkeus Pharmaceuticals, Inc. operates as a clinical stage drug discovery and development company. The company was founded by Leonide Saad, Joshua Boger and Ilyas Washington in 2010 and is headquartered in Boston, MA. | Director/Board Member | 01.01.2023 |
Ehemalige bekannte Positionen von Michel Dahan
| Unternehmen | Position | Ende |
|---|---|---|
Inspiration Biopharmaceuticals, Inc.
 Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Inspiration Biopharmaceuticals, Inc. produces intravenous recombinant therapies and develops non-invasive applications. It offers its products for the hemophilia community. The company was founded by Scott Donnelly Martin and John Read Taylor, Jr. on April 28, 2006 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01.01.2013 |
Ipsen, Inc.
 Ipsen, Inc. Industrial MachineryProducer Manufacturing Ipsen, Inc. design and manufacture of industrial atmosphere and vacuum heat-treating systems and supervisory controls systems. It offers vacuum furnaces, atmosphere furnaces, and PdMetrics software platform. The company was founded by Harold Ipsen in 1948 and is headquartered in Cherry Valley, IL. | Corporate Officer/Principal | 01.01.2010 |
Ausbildung von Michel Dahan
| École des Hautes Études Commerciales de Paris | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Inspiration Biopharmaceuticals, Inc.
Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Inspiration Biopharmaceuticals, Inc. produces intravenous recombinant therapies and develops non-invasive applications. It offers its products for the hemophilia community. The company was founded by Scott Donnelly Martin and John Read Taylor, Jr. on April 28, 2006 and is headquartered in Boston, MA. | Health Technology |
| Université Pierre et Marie Curie | Consumer Services |
Ipsen, Inc.
Ipsen, Inc. Industrial MachineryProducer Manufacturing Ipsen, Inc. design and manufacture of industrial atmosphere and vacuum heat-treating systems and supervisory controls systems. It offers vacuum furnaces, atmosphere furnaces, and PdMetrics software platform. The company was founded by Harold Ipsen in 1948 and is headquartered in Cherry Valley, IL. | Producer Manufacturing |
Alkeus Pharmaceuticals, Inc.
Alkeus Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Alkeus Pharmaceuticals, Inc. operates as a clinical stage drug discovery and development company. The company was founded by Leonide Saad, Joshua Boger and Ilyas Washington in 2010 and is headquartered in Boston, MA. | Retail Trade |
